Entrada Therapeutics Inc reports results for the quarter ended in January - Earnings Summary

Entrada Therapeutics

10/05/2024 13:01

* Entrada Therapeutics Inc  TRDA.OQ  reported quarterly
adjusted
earnings of 68 cents​​ per share for the quarter ended in
January, higher than the same quarter last year, when the
company reported EPS of -21 cents.  The mean expectation of
five analysts for the quarter was for a loss of 59 cents per
share. Wall Street expected results to range from $-1.10 to -1
cents per share.
    * Revenue rose 134% to $59.12 million from a year ago;
analysts
expected $14.98 million. 
    * Entrada Therapeutics Inc's reported EPS for the quarter
was 68
cents​.
    * The company reported quarterly net income of $23.5
million.
    * Entrada Therapeutics Inc shares had risen by 1.3% this
quarter and lost 4.8% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 11.6%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is  "buy."

Wall Street's median 12-month price target for Entrada
Therapeutics Inc is $21.00 
This summary was machine generated from LSEG data May 10 at
12:00 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -0.59          0.68           Beat
 Dec. 31 2023      -0.17          -0.29          Missed
 Sep. 30 2023      -0.74          1.02           Beat
 Jun. 30 2023      -0.69          -0.78          Missed